000 01515 a2200433 4500
005 20250514192011.0
264 0 _c20040819
008 200408s 0 0 eng d
022 _a0007-0920
024 7 _a10.1038/sj.bjc.6601946
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSenff-Ribeiro, A
245 0 0 _aCytotoxic effect of a new 1,3,4-thiadiazolium mesoionic compound (MI-D) on cell lines of human melanoma.
_h[electronic resource]
260 _bBritish journal of cancer
_cJul 2004
300 _a297-304 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCell Adhesion
_xdrug effects
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aCinnamates
_xpharmacology
650 0 4 _aCollagen
_xmetabolism
650 0 4 _aDrug Combinations
650 0 4 _aFibronectins
_xmetabolism
650 0 4 _aHumans
650 0 4 _aLaminin
_xmetabolism
650 0 4 _aMelanoma, Experimental
_xdrug therapy
650 0 4 _aProteoglycans
_xmetabolism
650 0 4 _aSkin Neoplasms
_xdrug therapy
650 0 4 _aThiadiazoles
650 0 4 _aThiazoles
_xpharmacology
650 0 4 _aTumor Cells, Cultured
700 1 _aEchevarria, A
700 1 _aSilva, E F
700 1 _aFranco, C R C
700 1 _aVeiga, S S
700 1 _aOliveira, M B M
773 0 _tBritish journal of cancer
_gvol. 91
_gno. 2
_gp. 297-304
856 4 0 _uhttps://doi.org/10.1038/sj.bjc.6601946
_zAvailable from publisher's website
999 _c14905617
_d14905617